Arizona Oncology Associates — Tucson, Arizona

Public research footprint of Arizona Oncology Associates, compiled from the ClinicalTrials.gov public registry.

193

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Estrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or… · Relapsed/Refractory Follicular Lymphoma · Multiple Myeloma

Recently updated registry entries

NCT03383458 — A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk… (Active Not Recruiting)
NCT02446600 — Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib… (Active Not Recruiting)
NCT04224493 — A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Arizona Oncology Associates?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.